Market Currents
EU antitrust regulators end a probe into AstraZeneca (AZN) and Swiss rival Nycomed after being...
-
Thursday, March 1, 2012, 7:53 AM ETEU antitrust regulators end a probe into AstraZeneca (AZN) and Swiss rival Nycomed after being unable to find evidence of "pay-for-delay" deals in which the drug firms would try to hinder the entry of cheaper generic treatments into the market.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
